Detection of injury-induced vascular remodeling by targeting activated αvβ3 integrin in vivo

Circulation

Volumn 110, Issue 1, 2004, Pages 84-90

  Sadeghi, Mehran M ^a,b   Krassilnikova, Svetlana ^a,b   Zhang, Jiasheng ^a,b   Gharaei, Amir A ^a,b   Fassaei, Hooman Rastegar ^a,b   Esmailzadeh, Leila ^a,b   Kooshkabadi, Ali ^a,b   Edwards, Scott ^c   Yalamanchili, Padmaja ^c   Harris, Thomas D ^c   Sinusas, Albert J ^a   Zaret, Barry L ^a   Bender, Jeffrey R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Arteries; Imaging; Nuclear medicine; Restenosis

Indexed keywords

APOLIPOPROTEIN E; INDIUM 111; KI 67 ANTIGEN; MANGANESE; REAGENT; RP 748; TA 145; TRACER; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL MIGRATION; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; KIDNEY CLEARANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING;

ANIMALS; APOLIPOPROTEINS E; ARTERIAL OCCLUSIVE DISEASES; CARBOCYANINES; CAROTID STENOSIS; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HETEROCYCLIC COMPOUNDS, 1-RING; HUMANS; INTEGRIN ALPHAVBETA3; MICE; MICE, KNOCKOUT; ORGANOMETALLIC COMPOUNDS; RADIOACTIVE TRACERS; SULFONAMIDES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 3042857522     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000133319.84326.70     Document Type: Article

References (21)

1. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028-1032.
2. Humphries MJ. Integrin structure. Biochem Soc Trans. 2000;28:311-339.
3. Cheresh DA. Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA. 1987;84:6471-6475.
4. Moiseeva EP. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res. 2001;52:372-386.
5. Horton MA, Taylor ML, Arnett TR, et al. Arg-Gly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res. 1991;195:368-375.
6. Eliceiri BP, Cheresh DA. Adhesion events in angiogenesis. Curr Opin Cell Biol. 2001;13:563-568.
7. Sajid M, Stouffer GA. The role of alpha(v)beta3 integrins in vascular healing. Thromb Haemost. 2002;87:187-193.
8. Sipkins DA, Cheresh DA, Kazemi MR, et al. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med. 1998;4:623-626.
9. Haubner R, Wester HJ, Reuning U, et al. Radiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting. J Nucl Med. 1999;40:1061-1071.
10. Matsuno H, Stassen JM, Vermylen J, et al. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 1994;90:2203-2206.
11. Choi ET, Engel L, Callow AD, et al. Inhibition of neointimal hyperplasia by blocking alphaVbeta3 integrin with a small peptide antagonist Gpen-GRGDSPCA. J Vasc Surg. 1994;19:125-134.
12. Srivatsa SS, Fitzpatrick LA, Tsao PW, et al. Selective alphavbeta3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: evidence for the functional importance of integrin alphavbeta3 and osteopontin expression during neointima formation. Cardiovasc Res. 1997;36:408-428.
13. Harris TD, Kalogeropoulos S, Nguyen T, et al. Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy. Cancer Biother Radiopharm. 2003;18:627-641.
14. Gimbrone MA Jr, Cotran RS, Folkman J. Human vascular endothelial cells in culture: growth and DNA synthesis. J Cell Biol. 1974;60:673-684.
15. Sadeghi MM, Collinge M, Pardi R, et al. Simvastatin modulates cytokine-mediated endothelial cell adhesion molecule induction: involvement of an inhibitory G protein. J Immunol. 2000;165:2712-2718.
16. De Geest B, Zhao Z, Collen D, et al. Effects of adenovirus-mediated human apo A-I gene transfer on neointima formation after endothelial denudation in apo E-deficient mice. Circulation. 1997;96:4349-4356.
17. Takagi J, Petre BM, Walz T, et al. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell. 2002;110:599-511.
18. Byzova TV, Plow EF. Activation of alphaVbeta3 on vascular cells controls recognition of prothrombin. J Cell Biol. 1998;143:2081-2092.
19. Pampori N, Hato T, Stupack DG, et al. Mechanisms and consequences of affinity modulation of integrin alpha(V)beta(3) detected with a novel patch-engineered monovalent ligand. J Biol Chem. 1999;274:21609-21616.
20. Blankenberg FG, Strauss HW. Nuclear medicine applications in molecular imaging. J Magn Reson Imaging. 2002;16:352-361.
21. Liu L, Schwartz BR, Tupper J, et al. The GTPase Rap1 regulates phorbol 12-myristate 13-acetate-stimulated but not ligand-induced beta 1 integrin-dependent leukocyte adhesion. J Biol Chem. 2002;277:40893-40900.